|1.||Fujii, Tomohito: 2 articles (02/2004 - 11/2003)|
|2.||Koizumi, Naoyuki: 2 articles (02/2004 - 11/2003)|
|3.||Bandoh, Koji: 1 article (02/2004)|
|4.||Horiuchi, Toshi: 1 article (02/2004)|
|5.||Kinoshita, Setsuo: 1 article (02/2004)|
|6.||Yamauchi, Yukinao: 1 article (02/2004)|
|7.||Saito, Tomoyuki: 1 article (02/2004)|
|8.||Fuse, Saeko: 1 article (02/2004)|
|9.||Nakagawa, Takayoshi: 1 article (11/2003)|
|10.||Okada, Makoto: 1 article (11/2003)|
|1.||Breast Neoplasms (Breast Cancer)
02/01/2004 - "To elucidate its usefulness as a therapeutic drug for postmenopausal breast cancer, we examined the breast cancer cell proliferation- and breast tumor growth-inhibitory activity of TZS-8478 in postmenopausal breast cancer model rats. "
02/01/2004 - "The above mentioned results suggested that TZS-8478 may be useful as a therapeutic drug for estrogen-dependent postmenopausal breast cancer."
02/01/2004 - "Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats."
11/01/2003 - "The identification of a potent steroid sulfatase inhibitor without estrogenicity, such as TZS-8478, should be of considerable value in evaluating the potential of steroid sulfatase inhibition for breast tumor therapy."
02/01/2004 - "Regarding nitrosomethylurea (NMU)-induced postmenopausal breast cancer models, furthermore, TZS-8478 (0.5 mg/kg per day) markedly inhibited the estrone sulfate-stimulated growth of breast tumors similarly to estrone sulfate-depletion. "
|1.||Steryl-Sulfatase (Steroid Sulfatase)
|6.||estrone sulfate (Evex)